fibrodysplasia ossificans progressiva Archives
Drug trial shows reduced abnormal bone formation in those with fibrodysplasia ossificans progressiva
Sep. 28, 2023—A Vanderbilt clinical trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva.
